Capital Advisor Network »

Alnylam Pharmaceuticals shares owned by Capital Advisor Network

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Capital Advisor Network from 13F filings

Historical chart of Capital Advisor Network investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Capital Advisor Network consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Capital Advisor Network

Quarter filed Position value Share count Share price at filing
2026-06-30 $14k 46 301.02

More positions owned by Capital Advisor Network

iShares Core S&P 500 ETF Etf (IVV)
Invesco QQQ Trust Series 1 Etf (QQQ)
Vanguard Growth ETF Etf (VUG)
Vanguard Value ETF Etf (VTV)
SPDR Dow Jones Industrial Average ETF Trust Etf (DIA)
iShares Core S&P Mid-Cap ETF Etf (IJH)
iShares MSCI USA Min Vol Factor ETF Etf (USMV)
SPDR Gold Shares Etf (GLD)
Vanguard FTSE Developed Markets ETF Etf (VEA)
WisdomTree Bloomberg U.S. Dollar Bullish Fund Etf (USDU)
THOR Index Rotation ETF Etf (THIR)
THOR Equal Weight Low Volatility ETF Etf (THLV)
iShares Treasury Floating Rate Bond ETF Etf (TFLO)
iShares Silver Trust Etf (SLV)
Graniteshares Gold Trust Common Stock (BAR)

View all positions for Capital Advisor Network

Top funds holding Alnylam Pharmaceuticals

FMR
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Wellington Management Company
Orbis Allan Gray
Dodge & Cox
Two Sigma Investments
American Century Companies

View all funds holding Alnylam Pharmaceuticals